Emtriva is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Emtricitabine.
| Product ID | 70518-1847_8125e09e-a04f-4294-e053-2a91aa0a1835 |
| NDC | 70518-1847 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Emtriva |
| Generic Name | Emtricitabine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-02-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021500 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | EMTRICITABINE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-02-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021500 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-02-04 |
| Ingredient | Strength |
|---|---|
| EMTRICITABINE | 200 mg/1 |
| SPL SET ID: | bdee7e7a-688e-4171-a8cf-deefc42bfb04 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 46014-0601 | Emtriva | emtricitabine |
| 53808-0801 | Emtriva | emtricitabine |
| 61958-0601 | Emtriva | EMTRICITABINE |
| 61958-0602 | Emtriva | EMTRICITABINE |
| 70518-1847 | Emtriva | EMTRICITABINE |
| 69097-642 | emtricitabine | emtricitabine |
| 70518-2906 | emtricitabine | emtricitabine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EMTRIVA 78239710 2852092 Live/Registered |
Gilead Sciences, Inc. 2003-04-18 |